Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance

Journal of Immunology

Volumn 189, Issue 2, 2012, Pages 804-812

  Kheradmand, Taba ^a   Wang, Shusen ^a   Bryant, Jane ^a   Tasch, James J ^a   Lerret, Nadine ^a   Pothoven, Kathryn L ^a   Houlihan, Josetta L ^a   Miller, Stephen D ^a   Zhang, Zheng J ^a   Luo, Xunrong ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANAMIDE; ETHYLENECARBODIIMIDE; GLYCOPROTEIN P 15095; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CLONAL ANERGY; DENDRITIC CELL; DIABETES MELLITUS; DONOR SPLENOCYTE INFUSION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; LYMPHATIC DRAINAGE; LYMPHOCYTE HOMING; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION TOLERANCE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN-PRESENTING CELLS; CARBODIIMIDES; CROSS-LINKING REAGENTS; GENE KNOCK-IN TECHNIQUES; GRAFT SURVIVAL; INFUSIONS, INTRAVENOUS; ISOANTIGENS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; PHAGOCYTES; SIGNAL TRANSDUCTION; SPLEEN; TRANSPLANTATION TOLERANCE;

EID: 84863632604     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103705     Document Type: Article

References (49)

1. Goulmy, E., E. Blokland, W. Fassbinder, G. Persijn, and J. J. van Rood. 1985. Occurrence of posttransplant donor-specific cell-mediated lympholysis nonreactivity in renal allograft recipients with perioperative transfusions only. Transplantation 39: 105-107. (Pubitemid 15188809)
2. Bućin, D. 1988. Adverse effect of blood transfusion on the long-term outcome of kidney transplantation. Exp. Clin. Immunogenet. 5: 39-47.
3. Bućin, D. 1988. Blood transfusion in renal transplantation: the induction of tolerance by incompatibility for class I antigen. Med. Hypotheses 27: 19-27.
4. van Twuyver, E., R. J. Mooijaart, I. J. ten Berge, A. R. van der Horst, J. M. Wilmink, W. M. Kast, C. J. Melief, and L. P. de Waal. 1991. Pretransplantation blood transfusion revisited. N. Engl. J. Med. 325: 1210-1213.
5. Stumpf, C., C. Lehner, S. Eskafi, D. Raaz, A. Yilmaz, S. Ropers, A. Schmeisser, J. Ludwig, W. G. Daniel, and C. D. Garlichs. 2003. Enhanced levels of CD154 (CD40 ligand) on platelets in patients with chronic heart failure. Eur. J. Heart Fail. 5: 629-637. (Pubitemid 38043968)
6. Stumpf, C., C. Lehner, A. Yilmaz, W. G. Daniel, and C. D. Garlichs. 2003. Decrease of serum levels of the anti-inflammatory cytokine interleukin-10 in patients with advanced chronic heart failure. Clin. Sci. 105: 45-50. (Pubitemid 36819575)
7. Knosalla, C., B. Gollackner, and D. K. Cooper. 2002. Anti-CD154 monoclonal antibody and thromboembolism revisted. Transplantation 74: 416-417.
8. Knosalla, C., B. Gollackner, F. J. Dor, and D. K. Cooper. 2002. Therapeutic interventions in xenotransplantation. Curr. Drug Targets Cardiovasc. Haematol. Disord. 2: 105-119. (Pubitemid 36519539)
9. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165: 302-319. (Pubitemid 17019817)
10. Turley, D. M., and S. D. Miller. 2007. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J. Immunol. 178: 2212-2220. (Pubitemid 46233419)
11. Miller, S. D., D. M. Turley, and J. R. Podojil. 2007. Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease. Nat. Rev. Immunol. 7: 665-677. (Pubitemid 47327394)
12. Fife, B. T., I. Guleria, M. Gubbels Bupp, T. N. Eagar, Q. Tang, H. Bour-Jordan, H. Yagita, M. Azuma, M. H. Sayegh, and J. A. Bluestone. 2006. Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. J. Exp. Med. 203: 2737-2747. (Pubitemid 44833349)
13. Eagar, T. N., D. M. Turley, J. Padilla, N. J. Karandikar, L. Tan, J. A. Bluestone, and S. D. Miller. 2004. CTLA-4 regulates expansion and differentiation of Th1 cells following induction of peripheral T cell tolerance. J. Immunol. 172: 7442-7450. (Pubitemid 38747606)
14. Kheradmand, T., S.Wang, R. F. Gibly, X. Zhang, S. Holland, J. Tasch, J. G. Graham, D. B. Kaufman, S. D. Miller, L. D. Shea, and X. Luo. 2011. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. Biomaterials 32: 4517-4524.
15. Luo, X., K. L. Pothoven, D. McCarthy, M. DeGutes, A. Martin, D. R. Getts, G. Xia, J. He, X. Zhang, D. B. Kaufman, and S. D. Miller. 2008. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms. Proc. Natl. Acad. Sci. USA 105: 14527-14532.
16. + regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. Transplantation 79: 1091-1096.
17. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
18. Grubin, C. E., S. Kovats, P. deRoos, and A. Y. Rudensky. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of MHC class IIbound self-peptides. Immunity 7: 197-208. (Pubitemid 27392012)
19. Refaeli, Y., L. Van Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196: 999-1005.
20. + direct pathway: level of priming determines acute versus chronic rejection. Transplantation 85: 247-255.
21. Luo, X., Q. Zhang, V. Liu, Z. Xia, K. L. Pothoven, and C. Lee. 2008. Cutting edge: TGF-β-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J. Immunol. 180: 2757-2761.
22. Smarr, C. B., C. L. Hsu, A. J. Byrne, S. D. Miller, and P. J. Bryce. 2011. Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy. J. Immunol. 187: 5090-5098.
23. Watson, D., M. Hu, G. Y. Zhang, Y. M. Wang, and S. I. Alexander. 2009. Tolerance induction by removal of alloreactive T cells: in-vivo and pruning strategies. Curr. Opin. Organ Transplant. 14: 357-363.
24. Wood, S. C., G. Lu, B. E. Burrell, and D. K. Bishop. 2008. Transplant acceptance following anti-CD4 versus anti-CD40L therapy: evidence for differential maintenance of graft-reactive T cells. Am. J. Transplant. 8: 2037-2048.
25. Jenkins, M. K., J. D. Ashwell, and R. H. Schwartz. 1988. Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J. Immunol. 140: 3324-3330.
26. Gökmen, M. R., G. Lombardi, and R. I. Lechler. 2008. The importance of the indirect pathway of allorecognition in clinical transplantation. Curr. Opin. Immunol. 20: 568-574.
27. Taylor, A. L., S. L. Negus, M. Negus, E. M. Bolton, J. A. Bradley, and G. J. Pettigrew. 2007. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity. Transplantation 83: 931-937. (Pubitemid 46682735)
28. Noorchashm, H., A. J. Reed, S. Y. Rostami, R. Mozaffari, G. Zekavat, B. Koeberlein, A. J. Caton, and A. Naji. 2006. B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection. J. Immunol. 177: 7715-7722. (Pubitemid 44846287)
29. Perruche, S., P. Zhang, Y. Liu, P. Saas, J. A. Bluestone, andW. Chen. 2008. CD3- specific antibody-induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells. Nat. Med. 14: 528-535. (Pubitemid 351655213)
30. + T cells in a tolerant environment depend on timing and place of antigen exposure. Am. J. Transplant. 12: 576-589.
31. Thomson, A. W. 2010. Tolerogenic dendritic cells: all present and correct? Am. J. Transplant. 10: 214-219.
32. Hill, M., and M. C. Cuturi. 2010. Negative vaccination by tolerogenic dendritic cells in organ transplantation. Curr. Opin. Organ Transplant. 15: 738-743.
33. Wahl, S.M., and W. Chen. 2005. Transforming growth factor-b-induced regulatory T cells referee inflammatory and autoimmune diseases. Arthritis Res. Ther. 7: 62-68. (Pubitemid 40439440)
34. Roncarolo, M. G., S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M. K. Levings. 2006. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212: 28-50. (Pubitemid 44116698)
35. Palafox, D., L. Llorente, J. Alberú, A. Torres-Machorro, N. Camorlinga, C. Rodríguez, and J. Granados. 2010. The role of indoleamine 2,3 dioxygenase in the induction of immune tolerance in organ transplantation. Transplant. Rev. (Orlando) 24: 160-165.
36. Jia, L., P. Tian, and C. Ding. 2009. Immunoregulatory effects of indoleamine 2,3-dioxygenase in transplantation. Transpl. Immunol. 21: 18-22.
37. Getts, D. R., D. M. Turley, C. E. Smith, C. T. Harp, D. McCarthy, E. M. Feeney, M. T. Getts, A. J. Martin, X. Luo, R. L. Terry, et al. 2011. Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells. J. Immunol. 187: 2405-2417.
38. Blair, P. J., J. L.Riley, D. M. Harlan,R. Abe, D. K. Tadaki, S.C. Hoffmann, L.White, T. Francomano, S. J. Perfetto, A. D. Kirk, and C. H. June. 2000. CD40 ligand (CD154) triggers a short-term CD4+ T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J. Exp. Med. 191: 651-660.
39. Yashiro, Y., X. G. Tai, K. Toyo-oka, C. S. Park, R. Abe, T. Hamaoka, M. Kobayashi, S. Neben, and H. Fujiwara. 1998. A fundamental difference in the capacity to induce proliferation of naive T cells between CD28 and other costimulatory molecules. Eur. J. Immunol. 28: 926-935. (Pubitemid 28116206)
40. Wekerle, T., J. Kurtz, M. Sayegh, H. Ito, A. Wells, S. Bensinger, J. Shaffer, L. Turka, and M. Sykes. 2001. Peripheral deletion after bone marrow transplantation with costimulatory blockade has features of both activation-induced cell death and passive cell death. J. Immunol. 166: 2311-2316. (Pubitemid 32173463)
41. Lehnert, A. M., S. Yi, J. S. Burgess, and P. J. O'Connell. 2000. Pancreatic islet xenograft tolerance after short-term costimulation blockade is associated with increased CD4+ T cell apoptosis but not immune deviation. Transplantation 69: 1176-1185. (Pubitemid 30217603)
42. + T cell populations. J. Immunol. 185: 4705-4713.
43. Jenkins, M. K., H. H. Chu, J. B. McLachlan, and J. J. Moon. 2010. On the composition of the preimmune repertoire of T cells specific for peptide-major histocompatibility complex ligands. Annu. Rev. Immunol. 28: 275-294.
44. Davies, J. D., L. Y. Leong, A. Mellor, S. P. Cobbold, and H. Waldmann. 1996. T cell suppression in transplantation tolerance through linked recognition. J. Immunol. 156: 3602-3607. (Pubitemid 26137645)
45. Cobbold, S. P., E. Adams, K. F. Nolan, F. S. Regateiro, and H. Waldmann. 2010. Connecting the mechanisms of T-cell regulation: dendritic cells as the missing link. Immunol. Rev. 236: 203-218.
46. Yang, L., B. DuTemple, R. M. Gorczynski, G. Levy, and L. Zhang. 1999. Evidence for epitope spreading and active suppression in skin graft tolerance after donor-specific transfusion. Transplantation 67: 1404-1410. (Pubitemid 29282981)
47. Martin, A. J., D. McCarthy, C. Waltenbaugh, G. Goings, X. Luo, and S. D. Miller. 2010. Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation. J. Immunol. 185: 3326-3336.
48. Quezada, S. A., B. Fuller, L. Z. Jarvinen, M. Gonzalez, B. R. Blazar, A. Y. Rudensky, T. B. Strom, and R. J. Noelle. 2003. Mechanisms of donor-specific transfusion tolerance: preemptive induction of clonal T-cell exhaustion via indirect presentation. Blood 102: 1920-1926. (Pubitemid 37022594)
49. Quezada, S. A., L. Z. Jarvinen, E. F. Lind, and R. J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22: 307-328. (Pubitemid 38680425)